Genelux Corporation (GNLX) is an innovative clinical-stage biopharmaceutical firm headquartered in Westlake Village, California, dedicated to revolutionizing cancer treatment through its proprietary oncolytic viral immunotherapy platform. Focused on aggressive solid tumors, Genelux develops therapies designed to mobilize and amplify the immune system's response against cancer, thereby enhancing patient outcomes. With a robust pipeline of therapeutics, the company is poised to make significant advancements in the evolving immunotherapy landscape, addressing unmet needs for patients battling challenging oncological conditions.
Recently
Rotate your device to landscape for a better chart view.
GNLX Price Trend and Signals
Rotate your device to landscape for a better chart view.
GNLX Short Volume (from FINRA off-exchange and ATS venues)
GNLX Short Interest
GNLX Option Volumes & Open Interests (aggregated)
GNLX Put Call Ratios and IV (aggregated)
GNLX Financials
2026-05-01Bullishmacd_signal
Golden cross below zero detected.
2026-04-23Bearishmacd_signal
Dead cross below zero detected.
2026-04-15Somewhat Bullishprice_signal
Monthly high detected.
2026-04-15Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2026-04-15Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2026-04-15Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2026-04-15Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2026-04-09Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2026-04-09Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2026-04-09Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2026-04-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2026-04-02Bullishmacd_signal
Golden cross below zero detected.
2026-04-01Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2026-03-30Somewhat Bearishprice_signal
Half-yearly low detected.
2026-03-27Bearishmacd_signal
Dead cross below zero detected.
2026-03-26Bullishmacd_signal
Golden cross below zero detected.
2026-03-25Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2026-03-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2026-03-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2026-03-20Somewhat Bearishprice_signal
Monthly low detected.
2026-03-19Somewhat Bearishprice_signal
Monthly low detected.
2026-03-17Bearishmacd_signal
Dead cross below zero detected.
2026-02-27Somewhat Bullishprice_signal
Monthly high detected.
2026-02-25Somewhat Bullishprice_signal
Monthly high detected.
2026-02-12Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2026-02-05Somewhat Bearishprice_signal
Half-yearly low detected.
2026-01-16Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-12-22Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-11-24Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-04-10Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-03-17Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-02-04Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.